Dedicated Bifurcation Stents vs. Regular Drug-Eluting Stents in Coronary Bifurcation Treatment: A Systematic Review and Meta-Analysis of 1-Year and 4-Year Outcomes, Including Left Main and Non-Left Main Subgroup Comparisons

<b>Background</b>: Dedicated bifurcation stents (DBS) were developed to overcome the limitations of conventional drug-eluting stents (DES) in percutaneous coronary intervention (PCI) for bifurcation lesions, but their clinical benefit remains uncertain. <b>Methods</b>: We conducted a systematic revi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jacek Bil, Adam Kern, Aneta I. Gziut-Rudkowska, Jarosław Zalewski, Krystian Bojko, Robert J. Gil
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2025-11-01
Edice:	Biomedicines
Témata:	sirolimus-eluting stent coronary artery disease coronary bifurcation dedicated bifurcation stent
On-line přístup:	https://www.mdpi.com/2227-9059/13/11/2763
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!